7 Insulin action and substrate competition
暂无分享,去创建一个
[1] L. Groop,et al. Metabolic Consequences of Sustained Suppression of Free Fatty Acids by Acipimox in Patients With NIDDM , 1993, Diabetes.
[2] L. Groop,et al. Contribution of muscle and liver to glucose-fatty acid cycle in humans. , 1993, The American journal of physiology.
[3] M. Walker,et al. A Double Blind Study of the Effect of Acipimox on Serum Lipids, Blood Glucose Control and Insulin Action in Non‐obese Patients with Type 2 Diabetes Mellitus , 1992, Diabetic medicine : a journal of the British Diabetic Association.
[4] M. Walker,et al. Metabolic Effects of Suppression of Nonesterified Fatty Acid Levels With Acipimox in Obese NIDDM Subjects , 1992, Diabetes.
[5] A. Vaag,et al. Effects of prolonged Acipimox treatment on glucose and lipid metabolism and on in vivo insulin sensitivity in patients with non-insulin dependent diabetes mellitus. , 1992, Acta endocrinologica.
[6] D. Owens,et al. The Effect of Acipimox in Patients with Type 2 Diabetes and Persistent Hyperlipidaemia , 1992, Diabetic medicine : a journal of the British Diabetic Association.
[7] L. Groop,et al. Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. , 1992, The American journal of physiology.
[8] L. Groop,et al. Reversal of steroid-induced insulin resistance by a nicotinic-acid derivative in man. , 1992, Metabolism: clinical and experimental.
[9] J. Foley,et al. Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes Mellitus , 1992, Diabetes Care.
[10] U Ruotsalainen,et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. , 1992, The Journal of clinical investigation.
[11] A. Vaag,et al. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.
[12] L. Groop,et al. Effects of weight loss on substrate oxidation, energy expenditure, and insulin sensitivity in obese individuals. , 1992, The American journal of clinical nutrition.
[13] A. Consoli,et al. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.
[14] J. Hill,et al. Glucose regulation of lipid metabolism in humans. , 1991, The American journal of physiology.
[15] M. Jensen,et al. How valid are isotopic measurements of fatty acid oxidation? , 1991, The American journal of physiology.
[16] A. Vaag,et al. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. , 1991, The Journal of clinical investigation.
[17] H. Yki-Järvinen,et al. No Reduction in Total Hepatic Glucose Output by Inhibition of Gluconeogenesis With Ethanol in NIDDM Patients , 1991, Diabetes.
[18] M. Walker,et al. Effect of glycemia and nonesterified fatty acids on forearm glucose uptake in normal humans. , 1991, The American journal of physiology.
[19] M. Mozzoli,et al. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. , 1991, The Journal of clinical investigation.
[20] H. Yki-Järvinen,et al. Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation. , 1991, The Journal of clinical endocrinology and metabolism.
[21] L. Groop,et al. Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. , 1991, The American journal of physiology.
[22] M. Jensen,et al. Effects of intravenous methyl palmoxirate on the turnover and oxidation of fatty acids in conscious dogs. , 1991, Metabolism: clinical and experimental.
[23] L. Groop,et al. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. , 1991, The Journal of clinical endocrinology and metabolism.
[24] M. Jensen. Regulation of forearm lipolysis in different types of obesity. In vivo evidence for adipocyte heterogeneity. , 1991, The Journal of clinical investigation.
[25] L. Groop,et al. Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. , 1991, The Journal of clinical investigation.
[26] W. Sheu,et al. Acute Changes in Plasma Non‐esterified Fatty Acid Concentration do not Change Hepatic Glucose Production in People with Type 2 Diabetes , 1990, Diabetic medicine : a journal of the British Diabetic Association.
[27] A. Consoli,et al. Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. , 1990, The Journal of clinical investigation.
[28] L. Groop,et al. Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans. , 1990, The American journal of physiology.
[29] J. Foley,et al. Inhibition of Hepatic Glucose Production by SDZ 51641 , 1990, Diabetes.
[30] M. Beylot,et al. Interactions of glucagon and free fatty acids with insulin in control of glucose metabolism. , 1990, Metabolism: clinical and experimental.
[31] L. Groop,et al. Obesity and insulin resistance in humans: a dose-response study. , 1990, Metabolism: clinical and experimental.
[32] E. Ferrannini,et al. Effects of Insulin on Hemodynamics and Metabolism in Human Forearm , 1990, Diabetes.
[33] E. Ferrannini,et al. Operation of Randle's Cycle in Patients With NIDDM , 1990, Diabetes.
[34] R G Shulman,et al. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.
[35] C. Venables,et al. In vitro study of human skeletal muscle strips: effect of nonesterified fatty acid supply on glucose storage. , 1989, Metabolism: clinical and experimental.
[36] L. Groop,et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.
[37] F. Lönnqvist,et al. Mechanisms underlying regional differences in lipolysis in human adipose tissue. , 1989, The Journal of clinical investigation.
[38] R. DeFronzo,et al. Time dependence of the interaction between lipid and glucose in humans. , 1989, The American journal of physiology.
[39] L. Groop,et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.
[40] E. Jéquier,et al. Impairment of glucose disposal by infusion of triglycerides in humans: role of glycemia. , 1989, The American journal of physiology.
[41] M. Taskinen,et al. Bedtime Insulin for Suppression of Overnight Free–Fatty Acid, Blood Glucose, and Glucose Production in NIDDM , 1989, Diabetes.
[42] E. Jéquier,et al. Regulation of glucose storage in obesity and diabetes: metabolic aspects. , 1988, Diabetes/metabolism reviews.
[43] E. Kraegen,et al. Effects of nonesterified fatty acid availability on tissue-specific glucose utilization in rats in vivo. , 1988, The Journal of clinical investigation.
[44] R. DeFronzo. The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.
[45] R. Wolfe,et al. Effect of elevated free fatty acids on glucose oxidation in normal humans. , 1988, Metabolism: clinical and experimental.
[46] E. Ferrannini. The theoretical bases of indirect calorimetry: a review. , 1988, Metabolism: clinical and experimental.
[47] R. DeFronzo,et al. Splanchnic Amino Acid and Glucose Metabolism During Amino Acid Infusion in Dogs , 1988, Diabetes.
[48] E. Ferrannini,et al. Metabolic interactions of amino acids and glucose in healthy humans , 1988 .
[49] G. Reaven,et al. Lowering of plasma glucose in diabetic rats by antilipolytic agents. , 1988, The American journal of physiology.
[50] A. Golay,et al. Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. , 1987, Metabolism: clinical and experimental.
[51] E. Barrett,et al. Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. , 1987, The Journal of clinical investigation.
[52] H. Yki-Järvinen,et al. Kinetics of glucose disposal in whole body and across the forearm in man. , 1987, The Journal of clinical investigation.
[53] E. Ferrannini,et al. Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. , 1987, Metabolism: clinical and experimental.
[54] E. Jéquier,et al. Metabolic factors in the insulin resistance in human obesity. , 1987, Metabolism: clinical and experimental.
[55] M. Mayr,et al. Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. , 1987, The Journal of clinical investigation.
[56] A. Golay,et al. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. , 1987, The Journal of clinical endocrinology and metabolism.
[57] A. Golay,et al. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations. , 1986, The Journal of clinical endocrinology and metabolism.
[58] R. DeFronzo,et al. Effect of free fatty acids on blood amino acid levels in human. , 1986, The American journal of physiology.
[59] S. Lillioja,et al. Increased Resting Metabolic Rates in Obese Subjects with Non-insulin-dependent Diabetes Mellitus and the Effect of Sulfonylurea Therapy , 1986, Diabetes.
[60] G. Reaven,et al. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. , 1985, The Journal of clinical endocrinology and metabolism.
[61] C. Bogardus,et al. Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy. , 1985, The Journal of clinical investigation.
[62] C. Emerson,et al. Euthyroid hyperthyroxinemia and thyroxine-binding prealbumin excess in islet cell carcinoma. , 1985, The Journal of clinical endocrinology and metabolism.
[63] L. Mandarino,et al. Mechanism of hyperglycemia and response to treatment with an inhibitor of fatty acid oxidation in a patient with insulin resistance due to antiinsulin receptor antibodies. , 1984, The Journal of clinical endocrinology and metabolism.
[64] B V Howard,et al. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. , 1984, The Journal of clinical investigation.
[65] B. Howard,et al. The antilipolytic action of insulin in obese subjects with resistance to its glucoregulatory action. , 1984, The Journal of clinical endocrinology and metabolism.
[66] J. H. Shaw,et al. Inhibitory effect of plasma free fatty acids on glucose production in the conscious dog. , 1984, The American journal of physiology.
[67] R. DeFronzo,et al. Effect of fatty acids on glucose production and utilization in man. , 1983, The Journal of clinical investigation.
[68] S. Blumenthal. Stimulation of gluconeogenesis by palmitic acid in rat hepatocytes: evidence that this effect can be dissociated from the provision of reducing equivalents. , 1983, Metabolism: clinical and experimental.
[69] P. Lönnroth,et al. Insulin Binding and Responsiveness in Fat Cells from Patients with Reduced Glucose Tolerance and Type II Diabetes , 1983, Diabetes.
[70] R. DeFronzo,et al. Effect of long chain triglyceride infusion on glucose metabolism in man. , 1982, Metabolism: clinical and experimental.
[71] P. Arner,et al. The antilipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia, and starvation. , 1981, Metabolism: clinical and experimental.
[72] P. Savage,et al. Evidence for marked sensitivity to the antilipolytic action of insulin in obese maturity-onset diabetics. , 1979, Metabolism: clinical and experimental.
[73] G. Tutwiler,et al. Methyl 2-Tetradecylglycidate, An Orally Effective Hypoglycemic Agent that Inhibits Long Chain Fatty Acid Oxidation Selectively , 1979, Diabetes.
[74] M. Rennie,et al. Inhibition of glucose uptake and glycogenolysis by availability of oleate in well-oxygenated perfused skeletal muscle. , 1977, The Biochemical journal.
[75] K. Kim,et al. Mechanism of palmityl coenzyme A inhibition of liver glycogen synthase. , 1977, The Journal of biological chemistry.
[76] M. Rennie,et al. Effects of increased plasma fatty acids on glycogen utilization and endurance. , 1977, Journal of applied physiology: respiratory, environmental and exercise physiology.
[77] G. Dagenais,et al. Free fatty acid oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm. , 1976, The Journal of clinical investigation.
[78] O. Wieland,et al. The influence of insulin on glucose and fatty acid metabolism in the isolated perfused rat hind quarter. , 1975, Hoppe-Seyler´s Zeitschrift für physiologische Chemie.
[79] N. Ruderman,et al. Glucose Metabolism in Rat Skeletal Muscle at Rest: Effect of Starvation, Diabetes, Ketone Bodies and Free Fatty Acids , 1974, Diabetes.
[80] E. Balasse,et al. Operation of the “Glucose‐Fatty Acid Cycle” during Experimental Elevations of Plasma Free Fatty Acid Levels in Man , 1974, European journal of clinical investigation.
[81] E. Jéquier,et al. Carbohydrate and lipid oxidation in normal human subjects: its influence on glucose tolerance and insulin response to glucose. , 1972, Metabolism: clinical and experimental.
[82] J. Felber,et al. Studies on the metabolic effects induced in the rat by a high-fat diet. Inhibition of pyruvate metabolism in diaphragm in vitro and its relation to the oxidation of fatty acids. , 1972, European journal of biochemistry.
[83] C. H. Beatty,et al. Interrelation of carbohydrate and palmitate metabolism in skeletal muscle. , 1971, The American journal of physiology.
[84] N. Ruderman,et al. Role of free fatty acids in glucose homeostasis. , 1969, Archives of internal medicine.
[85] D. Kipnis,et al. Effects of fatty acids on carbohydrate and fatty acid metabolism of rat diaphragm. , 1968, The American journal of physiology.
[86] B. Issekutz,et al. Oxidation of plasma FFA in lean and obese humans. , 1968, Metabolism: clinical and experimental.
[87] W. Reitsma. The relationship between serum free fatty acids and blood sugar in non-obese and obese diabetics. , 2009, Acta medica Scandinavica.
[88] L. Madison,et al. Physiologic Effects of Metabolic Fuels on Carbohydrate Metabolism: I. Acute Effect of Elevation of Plasma Free Fatty Acids on Hepatic Glucose Output, Peripheral Glucose Utilization, Serum Insulin, and Plasma Glucagon Levels , 1967, Diabetes.
[89] W. Danforth. GLYCOGEN SYNTHETASE ACTIVITY IN SKELETAL MUSCLE. INTERCONVERSION OF TWO FORMS AND CONTROL OF GLYCOGEN SYNTHESIS. , 1965, The Journal of biological chemistry.
[90] E. Newsholme,et al. Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. , 1964, The Biochemical journal.
[91] P. J. Randle,et al. Regulation of glucose uptake by muscles. 10. Effects of alloxan-diabetes, starvation, hypophysectomy and adrenalectomy, and of fatty acids, ketone bodies and pyruvate, on the glycerol output and concentrations of free fatty acids, long-chain fatty acyl-coenzyme A, glycerol phosphate and citrate-cycl , 1964, The Biochemical journal.
[92] E. Newsholme,et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.
[93] P. J. Randle,et al. Regulation of Glucose Uptake by Muscle , 1962 .
[94] I. Fritz. Factors influencing the rates of long-chain fatty acid oxidation and synthesis in mammalian systems. , 1961, Physiological reviews.
[95] V. Dole,et al. An Abnormality of Nonesterified Fatty Acid Metabolism in Diabetes Mellitus , 1957, Diabetes.